Une découverte susceptible de valoir un prix Nobel par les scientifiques de VectorBuilder révèle les mécanismes fondamentaux du développement
Dr. Bruce Lahn and his team at VectorBuilder have unveiled a groundbreaking technique, Potency-Seq, which measures the transcriptional potential of genes, shedding light on the mechanisms of cellular differentiation. This innovative approach enables researchers to determine whether silent genes retain the capacity for activation or have permanently lost this ability. Their findings reveal that as stem cells differentiate into specialized cell types, their genomes progressively lose transcriptional potential, with an increasing number of genes becoming irreversibly “occluded” and unable to respond to transcription factors, a process termed occlusis.
The implications of this discovery are profound. By establishing that the fundamental distinction between cell types lies not only in their expression profiles but also in the transcriptional activity of their genomes, the research addresses a long-standing question in developmental biology: why differentiated cells cannot revert to a more plastic state. The study identifies a key gene, Esrrb, responsible for re-establishing transcriptional potential in naive pluripotent stem cells, highlighting that occlusion is a default state of gene organization, where genes become silenced simply by being wrapped in nucleosomes. This understanding could revolutionize approaches to regenerative medicine and cellular therapies by providing insights into how to maintain or restore cellular plasticity.
The discovery of occlusis and its underlying mechanisms could shift current research paradigms by emphasizing the importance of transcriptional accessibility in cell identity maintenance. This may accelerate drug development timelines aimed at targeting age-related diseases and degenerative conditions, as understanding how to manipulate gene occlusion could lead to novel therapeutic strategies to enhance healthspan and address the cellular dysfunctions associated with aging. Dr. Lahn’s initiative to establish a nonprofit foundation to further explore occlusis underscores the need for increased attention to this fundamental aspect of biology, which has critical implications for both aging research and therapeutic innovation.
Source: globenewswire.com